Operating Profit Reaches 13.5 Billion Won, Up 24% Year-on-Year

Driven by Stable Growth in Consumables Business

"We Will Continue to Strengthen Global Market Competitiveness"

JVM, a subsidiary of Hanmi Science, achieved its highest-ever quarterly revenue in the second quarter of this year.


On July 30, JVM announced provisional consolidated results for the second quarter, posting revenue of 49.3 billion won and operating profit of 13.5 billion won. These figures represent increases of 3.7% and 24% year-on-year, respectively.

JVM Achieves Record-High Quarterly Revenue of 49.3 Billion Won in Q2 View original image

By region, sales were split 49.2% domestic and 50.8% overseas (Europe 29.0%, North America 15.4%, other regions 6.5%), meaning that exports exceeded domestic sales.


In Korea, the consumables business provided stable support for performance growth. The company also expanded its product portfolio by launching a new product: a storage cabinet designed for the secure storage and management of controlled substances.


In exports, shipments increased, driven mainly by dispensing automation equipment and key consumables. JVM is enhancing its product portfolio, focusing on its robot-based automatic dispensing systems, MENITH and COUNTMATE.


JVM plans to continue targeting the global market. Recently, the company accelerated efforts to expand its local production system by establishing a new plant in Suzhou, China, for the manufacture of automated pharmaceutical dispensing equipment.



JVM CEO Sangwook Kim stated, "We are maintaining solid growth momentum based on enhanced product competitiveness and a stable business foundation," adding, "We will continue to invest in research and development and expand the supply of high value-added automated dispensing solutions to bolster our competitiveness in global markets."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing